Back to search
Osteogenesis Imperfecta Type II
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Osteogenesis Imperfecta Type II trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Osteogenesis Imperfecta Type II trials you may qualify forThis is a study to evaluate the safety and effectiveness of repeated Mesenchymal Stromal Cells (MSC) infusions to patients with Type II or III osteogenesis impe…
This protocol was a prospective, Phase I study of allogeneic bone marrow transplantation (BMT) as the primary therapy for Osteogenesis Imperfecta Types II and I…